Department of Medicine and.
Department of Environmental Health Sciences and Engineering and.
Am J Respir Crit Care Med. 2023 Mar 15;207(6):721-730. doi: 10.1164/rccm.202203-0523OC.
Indoor air pollution represents a modifiable risk factor for respiratory morbidity in chronic obstructive pulmonary disease (COPD). The effects of indoor air pollution, as well as the impact of interventions to improve indoor air quality, on cardiovascular morbidity in COPD remain unknown. To determine the association between indoor particulate matter (PM) and heart rate variability (HRV), a measure of cardiac autonomic function tied to cardiovascular morbidity and mortality, as well as the impact of household air purifiers on HRV. Former smokers with moderate-severe COPD were recruited from a 6-month randomized controlled trial of a portable air cleaner intervention to undergo paired assessment of both in-home PM and HRV using 24-hour Holter monitoring at up to five time points. Primary outcomes were HRV measures tied to cardiovascular morbidity (standard deviation of normal-to-normal intervals [SDNN] and root mean square of successive differences between normal-to-normal intervals [RMSSD]). Eighty-five participants contributed 317 HRV measurements. A twofold increase in household PM ⩽2.5 µm in aerodynamic diameter was associated with decreases in SDNN (β, -2.98% [95% confidence interval (CI), -5.12 to -0.78]) and RMSSD (β, -4.57% [95% CI, -10.1 to -1.60]). The greatest effects were observed with ultrafine particles (<100 nm) (RMSSD; β, -16.4% [95% CI, -22.3 to -10.1]) and among obese participants. Participants randomized to the active air cleaner saw improvements in RMSSD (β, 25.2% [95% CI, 2.99 to 52.1]), but not SDNN (β, 2.65% [95% CI, -10.8 to 18.1]), compared with the placebo group. This is the first U.S. study to describe the association between household PM and cardiac autonomic function among individuals with COPD, as well as the potential cardiovascular health benefits of household air cleaners.
室内空气污染是慢性阻塞性肺疾病(COPD)呼吸道发病的一个可改变的危险因素。室内空气污染的影响,以及改善室内空气质量的干预措施对 COPD 心血管发病率的影响仍不清楚。为了确定室内颗粒物(PM)与心率变异性(HRV)之间的关系,HRV 是衡量心脏自主功能的指标,与心血管发病率和死亡率有关,以及家用空气净化器对 HRV 的影响。从中度至重度 COPD 的前吸烟者中招募了参加便携式空气净化器干预 6 个月随机对照试验的患者,使用 24 小时动态心电图监测进行家中 PM 和 HRV 的配对评估,最多在五个时间点进行。主要结局是与心血管发病率有关的 HRV 指标(正常-正常间期标准差[SDNN]和正常-正常间期连续差值的均方根[RMSSD])。85 名参与者提供了 317 次 HRV 测量。家庭 PM ⩽2.5 µm 时空气动力学直径增加两倍与 SDNN 降低相关(β,-2.98%[95%置信区间(CI),-5.12 至-0.78])和 RMSSD(β,-4.57%[95%CI,-10.1 至-1.60])。观察到的最大影响是超细颗粒(<100nm)(RMSSD;β,-16.4%[95%CI,-22.3 至-10.1])和肥胖参与者中。与安慰剂组相比,随机分配到活性空气净化器的参与者 RMSSD (β,25.2%[95%CI,2.99 至 52.1])有所改善,但 SDNN 没有改善(β,2.65%[95%CI,-10.8 至 18.1])。这是美国第一项描述家庭 PM 与 COPD 患者心脏自主功能之间关系的研究,以及家用空气净化器对心血管健康潜在益处的研究。